FDA Recalls Over 140,000 Bottles of Common Cholesterol Medication
The FDA has announced a recall of approximately 312,000 bottles of atorvastatin calcium tablets by Ascend Laboratories due to potential dissolution issues, which could affect the medication's effectiveness in treating high cholesterol.